Work

Nanoparticles Crossing the Blood–Brain Barrier: A Hope for Central Nervous System Disorders

Year: 2025

Type: article

Abstract: It has been estimated that about 1.5 million deaths occur due to central nervous system disorders. The problem is overcome by modern pharmaceutical technology by manufacturing nanoparticles. These are small particles that have an advantage over other drugs because they have the ability to pass through the blood–brain barrier, which is a structure in the brain that maintains the transport of substances and drugs between blood and brain. Nanoparticles are of different types. They may be polymeric, liposomal, or solid lipid nanoparticles. The main aim of nanoparticles is the target-specific delivery of drugs.

Source: Premier Journal of Neuroscience

DOI: 10.70389/pjn.100011

Authors: Muhammad Imran Qadir, Ayesha Altaf

Institution: Bahauddin Zakariya University

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4413745957